Educational purposes only. Not investment advice. Past performance does not guarantee future results. View full terms

LLY

Eli Lilly and Company β€’ Healthcare (#5 of 11)

$954.25
+34.48 (+3.75%)
View:
Close:$954.25
Vol:EXTREME(100%ile)
Ratio:1.92x
|
RSI:50(Neutral)
MACD:↑
β‰₯75%25-75%<25%
Vol.%
Sector Rotation
2026-04-01(10/10)
20d Strength (bar)
Strong (Β±4%)
Normal (-2~+3%)
5d Strength (normal: -1~+1%)
Relative Strength Trajectory
5d Strength
10d Strength
20d Strength
NASDAQ
10d early: 3~5%|20d confirm: 4~8.5%|>8.5% exhaustion
Analyst Actions
NEUTRAL
β–²0 Upβ–Ό1 Down1 Hold
Mar 30Guggenheim
–Buy
Mar 17HSBC
β–ΌHold β†’ Reduce
Price Targets
(60d mean: $1220, +27.8%)
BEARISH
β–²0 Raisesβ–Ό2 Lowers
Mar 30Guggenheim
$1168β†’$1163-0.4%
Mar 17HSBC
$1070β†’$850-20.6%
Trade Setup
Entry$954.25
Target$1012.94 (+6.2%)
Stop$895.56
R/R1.00
Risk-6.2%
Conv32 (LOW)
Size7 shares ($6,680)
Risk Metrics
Sharpe (20d)
-1.64Losing
Volatility (20d)
35.0%Normal
Beta (60d)
0.64Defensive
Alpha (20d)
-0.7%In Line
News Analysis
EN
δΈ­
ν•œ
ζ—₯

No analysis record found.